Ca2+ signaling in hypoxic pulmonary vasoconstriction: Effects of myosin light chain and Rho kinase antagonists

Jian Wang, Letitia Weigand, Joshua Foxson, Larissa Shimoda, J. T. Sylvester

Research output: Contribution to journalArticle

Abstract

Antagonists of myosin light chain (MLC) kinase (MLCK) and Rho kinase (ROK) are thought to inhibit hypoxic pulmonary vasoconstriction (HPV) by decreasing the concentration of phosphorylated MLC at any intracellular Ca2+ concentration ([Ca2+]i) in pulmonary arterial smooth muscle cells (PASMC); however, these antagonists can also decrease [Ca 2+]i. To determine whether MLCK and ROK antagonists alter Ca2+ signaling in HPV, we measured the effects of ML-9, ML-7, Y-27632, and HA-1077 on [Ca2+]i, Ca2+ entry, and Ca2+ release in rat distal PASMC exposed to hypoxia or depolarizing concentrations of KCl. We performed parallel experiments in isolated rat lungs to confirm the inhibitory effects of these agents on pulmonary vasoconstriction. Our results demonstrate that MLCK and ROK antagonists caused concentration-dependent inhibition of hypoxia-induced increases in [Ca2+]i in PASMC and HPV in isolated lungs and suggest that this inhibition was due to blockade of Ca2+ release from the sarcoplasmic reticulum and Ca2+ entry through store- and voltage-operated Ca2+ channels in PASMC. Thus MLCK and ROK antagonists might block HPV by inhibiting Ca2+ signaling, as well as the actin-myosin interaction, in PASMC. If effects on Ca2+ signaling were due to decreased phosphorylated myosin light chain concentration, their diversity suggests that MLCK and ROK antagonists may have acted by inhibiting myosin motors and/or altering the cytoskeleton in a manner that prevented achievement of required spatial relationships among the cellular components of the response.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume293
Issue number3
DOIs
StatePublished - Sep 2007

Fingerprint

Myosin-Light-Chain Kinase
rho-Associated Kinases
Vasoconstriction
Lung
Smooth Muscle Myocytes
Phosphotransferases
Myosin Light Chains
Myosins
Sarcoplasmic Reticulum
Cytoskeleton
Actins

Keywords

  • Angiotensin II
  • Calcium channels
  • Isolated rat lung
  • Pulmonary vascular resistance
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Cell Biology
  • Physiology

Cite this

Ca2+ signaling in hypoxic pulmonary vasoconstriction : Effects of myosin light chain and Rho kinase antagonists. / Wang, Jian; Weigand, Letitia; Foxson, Joshua; Shimoda, Larissa; Sylvester, J. T.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 293, No. 3, 09.2007.

Research output: Contribution to journalArticle

@article{09bc4f2a2ed34215a893c8440637b6d7,
title = "Ca2+ signaling in hypoxic pulmonary vasoconstriction: Effects of myosin light chain and Rho kinase antagonists",
abstract = "Antagonists of myosin light chain (MLC) kinase (MLCK) and Rho kinase (ROK) are thought to inhibit hypoxic pulmonary vasoconstriction (HPV) by decreasing the concentration of phosphorylated MLC at any intracellular Ca2+ concentration ([Ca2+]i) in pulmonary arterial smooth muscle cells (PASMC); however, these antagonists can also decrease [Ca 2+]i. To determine whether MLCK and ROK antagonists alter Ca2+ signaling in HPV, we measured the effects of ML-9, ML-7, Y-27632, and HA-1077 on [Ca2+]i, Ca2+ entry, and Ca2+ release in rat distal PASMC exposed to hypoxia or depolarizing concentrations of KCl. We performed parallel experiments in isolated rat lungs to confirm the inhibitory effects of these agents on pulmonary vasoconstriction. Our results demonstrate that MLCK and ROK antagonists caused concentration-dependent inhibition of hypoxia-induced increases in [Ca2+]i in PASMC and HPV in isolated lungs and suggest that this inhibition was due to blockade of Ca2+ release from the sarcoplasmic reticulum and Ca2+ entry through store- and voltage-operated Ca2+ channels in PASMC. Thus MLCK and ROK antagonists might block HPV by inhibiting Ca2+ signaling, as well as the actin-myosin interaction, in PASMC. If effects on Ca2+ signaling were due to decreased phosphorylated myosin light chain concentration, their diversity suggests that MLCK and ROK antagonists may have acted by inhibiting myosin motors and/or altering the cytoskeleton in a manner that prevented achievement of required spatial relationships among the cellular components of the response.",
keywords = "Angiotensin II, Calcium channels, Isolated rat lung, Pulmonary vascular resistance, Vascular smooth muscle",
author = "Jian Wang and Letitia Weigand and Joshua Foxson and Larissa Shimoda and Sylvester, {J. T.}",
year = "2007",
month = "9",
doi = "10.1152/ajplung.00141.2007",
language = "English (US)",
volume = "293",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Ca2+ signaling in hypoxic pulmonary vasoconstriction

T2 - Effects of myosin light chain and Rho kinase antagonists

AU - Wang, Jian

AU - Weigand, Letitia

AU - Foxson, Joshua

AU - Shimoda, Larissa

AU - Sylvester, J. T.

PY - 2007/9

Y1 - 2007/9

N2 - Antagonists of myosin light chain (MLC) kinase (MLCK) and Rho kinase (ROK) are thought to inhibit hypoxic pulmonary vasoconstriction (HPV) by decreasing the concentration of phosphorylated MLC at any intracellular Ca2+ concentration ([Ca2+]i) in pulmonary arterial smooth muscle cells (PASMC); however, these antagonists can also decrease [Ca 2+]i. To determine whether MLCK and ROK antagonists alter Ca2+ signaling in HPV, we measured the effects of ML-9, ML-7, Y-27632, and HA-1077 on [Ca2+]i, Ca2+ entry, and Ca2+ release in rat distal PASMC exposed to hypoxia or depolarizing concentrations of KCl. We performed parallel experiments in isolated rat lungs to confirm the inhibitory effects of these agents on pulmonary vasoconstriction. Our results demonstrate that MLCK and ROK antagonists caused concentration-dependent inhibition of hypoxia-induced increases in [Ca2+]i in PASMC and HPV in isolated lungs and suggest that this inhibition was due to blockade of Ca2+ release from the sarcoplasmic reticulum and Ca2+ entry through store- and voltage-operated Ca2+ channels in PASMC. Thus MLCK and ROK antagonists might block HPV by inhibiting Ca2+ signaling, as well as the actin-myosin interaction, in PASMC. If effects on Ca2+ signaling were due to decreased phosphorylated myosin light chain concentration, their diversity suggests that MLCK and ROK antagonists may have acted by inhibiting myosin motors and/or altering the cytoskeleton in a manner that prevented achievement of required spatial relationships among the cellular components of the response.

AB - Antagonists of myosin light chain (MLC) kinase (MLCK) and Rho kinase (ROK) are thought to inhibit hypoxic pulmonary vasoconstriction (HPV) by decreasing the concentration of phosphorylated MLC at any intracellular Ca2+ concentration ([Ca2+]i) in pulmonary arterial smooth muscle cells (PASMC); however, these antagonists can also decrease [Ca 2+]i. To determine whether MLCK and ROK antagonists alter Ca2+ signaling in HPV, we measured the effects of ML-9, ML-7, Y-27632, and HA-1077 on [Ca2+]i, Ca2+ entry, and Ca2+ release in rat distal PASMC exposed to hypoxia or depolarizing concentrations of KCl. We performed parallel experiments in isolated rat lungs to confirm the inhibitory effects of these agents on pulmonary vasoconstriction. Our results demonstrate that MLCK and ROK antagonists caused concentration-dependent inhibition of hypoxia-induced increases in [Ca2+]i in PASMC and HPV in isolated lungs and suggest that this inhibition was due to blockade of Ca2+ release from the sarcoplasmic reticulum and Ca2+ entry through store- and voltage-operated Ca2+ channels in PASMC. Thus MLCK and ROK antagonists might block HPV by inhibiting Ca2+ signaling, as well as the actin-myosin interaction, in PASMC. If effects on Ca2+ signaling were due to decreased phosphorylated myosin light chain concentration, their diversity suggests that MLCK and ROK antagonists may have acted by inhibiting myosin motors and/or altering the cytoskeleton in a manner that prevented achievement of required spatial relationships among the cellular components of the response.

KW - Angiotensin II

KW - Calcium channels

KW - Isolated rat lung

KW - Pulmonary vascular resistance

KW - Vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=34548409544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548409544&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00141.2007

DO - 10.1152/ajplung.00141.2007

M3 - Article

C2 - 17575009

AN - SCOPUS:34548409544

VL - 293

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 3

ER -